Figure 5: Therapeutic effects of HL-25 for model mice of HBC after the inoculation of MDA-MB-453 cells (A) Tumor volume of model mice of HBC treated with HL-25. (B) Tumor weight of model mice of HBC treated with HL-25 for 14 days. Error bars indicate S.D. (n=5 per group). Control: 5% glucose solution, DMPC liposomes: 136 mg/kg/day, HL-25: 136 mg/kg/day for DMPC.